IMRX

3.3802.03%
MD

Michael D. Bookman

Chief Legal Officer & Secretary

Mr. Michael D. Bookman, JD, also known as Mike, has been Chief Legal Officer of Immuneering Corporation since March 2023 and has been its Secretary since July 20, 2021 and also served as its General Counsel since July 20, 2021 until March 2023. Mr. Bookman served as the General Counsel and Secretary of Frequency Therapeutics, Inc. since 2019 until July 2021. In this role, he was a Member of the Executive Leadership Team and established and led Frequency’s Legal Department as its first in-house attorney. Mr. Bookman also played a key role in Frequency’s initial public offering in October 2019. Prior to his time at Frequency, he was an Associate at Latham & Watkins LLP, a leading international law firm where he worked on corporate transactional, securities and general business and governance matters, with an emphasis on representing high-growth technology and life sciences companies from October 2012 until August 2019. Mr. Bookman earned a Bachelor of Business Administration in Finance, summa cum laude from the University of Miami and earned his Juris Doctor with a concentration in Law and Business from the University of Virginia School of Law.

Positions